What are ambiguous genetic sexes, also known as disorders of sex development (DSD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Disorders of Sex Development (DSD): Understanding Ambiguous Genetic Sexes

Disorders of Sex Development (DSD) are congenital conditions associated with atypical chromosomal, gonadal, or anatomical sex development that lead to differences in the urogenital tract and reproductive system. 1

Definition and Classification

DSDs represent a spectrum of conditions where there is discordance between chromosomal, gonadal, and phenotypic sex. The terminology has evolved significantly over time, moving away from potentially stigmatizing terms like "hermaphrodite" or "intersex" toward more precise medical classifications.

The current classification system, established by the 2005 Chicago Consensus, organizes DSDs into three main categories:

  1. 46,XY DSD - Individuals with XY chromosomes but atypical male development
  2. 46,XX DSD - Individuals with XX chromosomes but atypical female development
  3. Sex Chromosome DSD - Variations in sex chromosome number or structure (e.g., 45,X/46,XY mosaicism)

Additional subcategories include:

  • Ovotesticular DSD (presence of both ovarian and testicular tissue)
  • 46,XX testicular DSD
  • 46,XY complete gonadal dysgenesis 1

Etiology and Pathophysiology

DSDs arise from disruptions in the complex process of sex determination and differentiation:

  • Sex determination factors are primarily transcriptional regulators that direct gonadal development
  • Sex differentiation factors are typically hormones and their receptors that guide development of internal and external genitalia 2

Genetic causes are numerous and heterogeneous, involving:

  • Mutations in genes controlling gonadal development
  • Alterations in androgen synthesis or action
  • Chromosomal abnormalities
  • Epigenetic mechanisms 3

Some cases may also be influenced by:

  • Maternal factors
  • Exposure to endocrine-disrupting chemicals 4

Clinical Presentation

The clinical presentation of DSDs varies widely depending on the specific condition:

  • Ambiguous genitalia - May include:

    • Clitoromegaly or micropenis
    • Hypospadias (urethral opening not at tip of penis)
    • Incomplete labial fusion or bifid scrotum
    • Cryptorchidism (undescended testes)
  • Internal reproductive structures - May include:

    • Streak gonads
    • Ovotestes (containing both ovarian and testicular tissue)
    • Rudimentary uterus or fallopian tubes in individuals with Y chromosome
    • Absence of expected structures
  • Hormonal abnormalities - May include:

    • Altered androgen production or sensitivity
    • Abnormal estrogen levels
    • Adrenal insufficiency in certain conditions

Diagnostic Approach

Diagnosis requires a structured, multidisciplinary approach:

  1. Clinical evaluation:

    • Detailed physical examination of external genitalia
    • Assessment of other physical features that may suggest syndromic conditions
  2. Laboratory investigations:

    • Karyotype analysis
    • Hormonal evaluation (testosterone, dihydrotestosterone, gonadotropins)
    • Biochemical tests for specific enzyme deficiencies
  3. Imaging studies:

    • Ultrasound or MRI to evaluate internal reproductive structures
    • Genitography when indicated
  4. Genetic testing:

    • Targeted gene sequencing for known DSD-associated genes
    • Chromosomal microarray
    • Next-generation sequencing panels
    • Whole exome/genome sequencing in complex cases 3, 5
  5. Histological examination:

    • Gonadal biopsy when indicated for diagnosis or tumor risk assessment

Management Considerations

Management of DSDs requires a multidisciplinary team approach including endocrinologists, urologists/surgeons, geneticists, psychologists, and social workers. Key aspects include:

  1. Gender assignment:

    • Should be made in the first weeks of life based on:
      • Specific diagnosis
      • Genital appearance
      • Potential fertility
      • Surgical requirements
      • Family and cultural considerations 1
  2. Surgical management:

    • Historically performed early, but current recommendations favor:
      • Individualized approach
      • Consideration of deferring genital surgery when possible
      • Informed consent and family involvement in decision-making 1, 5
  3. Hormonal management:

    • Replacement therapy for adrenal insufficiency if present
    • Sex hormone replacement at puberty if gonadal function is impaired 4
  4. Psychological support:

    • Ongoing counseling for patients and families
    • Support for gender identity development
    • Connection with peer support groups 5
  5. Long-term follow-up:

    • Monitoring for gonadal malignancy risk
    • Assessment of sexual function
    • Fertility considerations
    • Transition to adult care 4

Evolving Perspectives

The approach to DSDs has evolved significantly:

  • Moving from binary gender concepts toward recognition of biological diversity
  • Greater emphasis on patient autonomy and informed consent
  • Increased involvement of patient advocacy groups in developing care standards
  • Recognition that atypical sex development is not necessarily pathological 5

The traditional approach of urgent gender assignment and early surgical intervention has been questioned, with a shift toward more measured, individualized care that involves families in decision-making and considers long-term outcomes including quality of life 1.

Important Considerations and Pitfalls

  • Avoid outdated terminology like "hermaphrodite" or "pseudohermaphrodite" which can be stigmatizing
  • Recognize limitations of karyotype in predicting gender identity or optimal management
  • Be aware of potential tumor risk in certain DSDs, particularly those with Y chromosome material and gonadal dysgenesis
  • Consider psychological impact of medical interventions and repeated examinations
  • Maintain sensitivity to diverse cultural and family perspectives while providing evidence-based care

The management of DSDs continues to evolve as our understanding of the biological, psychological, and social aspects of these conditions improves, with increasing emphasis on individualized care, patient autonomy, and long-term quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Current concepts in disorders of sexual development.

Journal of clinical research in pediatric endocrinology, 2011

Research

Management of disorders of sex development.

Nature reviews. Endocrinology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.